# Richard Lipscombe

> Richard Lipscombe is a seed investor in Perth backing Medical and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Location: Perth, Australia
- Total investments: 1
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/richard-lipscombe-4b67013/?originalSubdomain=au

Richard Lipscombe is a seed investor in Perth focused on Medical and Health Care. Richard, a co-founder of the Company, is a highly practised business manager and protein chemist expert in analysing bio-molecules using proteomics techniques. He has an extensive expertise in chemistry, immunology, mass spectrometry, peptide synthesis, high performance computing and robotics.Richard has international experience in both scienceand business gained over a 29-year period in Australia, USA and the UK, including work in hospital and academic laboratories and commercial organisations. He completed his chemistry degree (MA) at Oxford University, his PhD in immunology at London University and was a Post-Doctoral scientist (molecular immunology) in a large research institution in Australia (Telethon Institute for Child Health Research).

## Contacts

5 contacts available for Richard Lipscombe: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/richard-lipscombe?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Diag-Nose.io | Diag-Nose Medical is a novel diagnostic tool that develops non-Invasive diagnostics for better rhinology treatments. The company is working on an affordable, rapid, and non-invasive self-test to determine the right treatment pathway for patients with acute sinusitis and to promote antibiotic stewardship for clinicians.Diag-Nose Medical flagshipproduct, the “RHINOSENSE” is a point-of-care test that combines non-invasive nasal sampling, lateral flow immunoassays, and host-immune markers to differentiate between viral, bacterial, and allergy mediated sinusitis. | $2M | Seed | Jan 30, 2025 | https://www.diag-nose.com.au/ |

1 of 1 investments shown.

## Co-investors
- [Breakthrough Victoria](https://shizune.co/investors/profile/breakthrough-victoria) — VC Fund, 1 deal together
- [Radar Ventures](https://shizune.co/investors/profile/radar-ventures) — VC Fund, 1 deal together
- [Specialty Physician Associates](https://shizune.co/investors/profile/specialty-physician-associates) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in Australia](https://shizune.co/investors/medical-angel-investors-australia)
- [Biotechnology Angel Investors in Oceania](https://shizune.co/investors/biotechnology-angel-investors-oceania)
- [Biotechnology Angel Investors in Australia](https://shizune.co/investors/biotechnology-angel-investors-australia)
- [Biotech Angel Investors in Australia](https://shizune.co/investors/biotech-angel-investors-australia)

## FAQ

### What does Richard Lipscombe invest in?

Richard Lipscombe invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Richard Lipscombe?

Public channels for Richard Lipscombe include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co